Abstract:Objective: The escalating challenge posed by multidrug-resistant tuberculosis (MDR-TB) necessitates the discovery of potent treatment agents. This study aims to synthesize, characterize, and evaluate the antitubercular potential of 33 novel 2,3-(4-aminobenzamido)benzoic acid derivatives ( 1–33 ). Methods: The synthesis involved a three-stage reaction series starting with p -aminobenzoic acid treated with concentrated hydrochloric acid to obtain its salt. This was further modified to ammonium benzoyl chloride using thionyl chloride. The ammonium benzoyl chloride was then condensed with 2 or 3 benzoic acids to yield the desired 2,3-(4-aminobenzamido)benzoic acid derivatives. The structures of these compounds were elucidated using FT-IR, HR-MS, 1 H, and 13 C NMR. Their antituberculosis activity was assessed using the Alamar blue dye assay against Mycobacterium tuberculosis H37RV. Results and Discussion: Out of the 33 synthesized compounds, 12 showed sensitivity to Mycobacterium tuberculosis (MTB). Notably, five compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) demonstrated significant potency, with minimal inhibitory concentrations (MICs) of 1.6 μg/mL, nearly 50 times lower than the standard drug. These results strongly suggest the potential of these compounds as effective tuberculosis therapeutics. Conclusions: The synthesized series of 2,3-(4-aminobenzamido)benzoic acid derivatives have shown promising antituberculosis activity. Specifically, compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) exhibited noteworthy potency. It is crucial that future research focuses on further screening the active compounds ( 2 – 4 ), ( 10 ), ( 14 ), ( 18 ), ( 19 ), ( 21 ), ( 26 ), ( 28 ), ( 30 ), and ( 33 ) for antimicrobial strains and evaluating compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) using the DHFR enzyme-specific assay to advance the development of effective tuberculosis treatments.

Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents

Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents

Synthesis and Biological Evaluation of Arylthiourea Derivatives with Antitubercular Activity

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides As Novel Antitubercular Agents.

Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections

Design, Synthesis, and Evaluation of the Antitubercular Activity of 5-Phenyl Substituted-5, 6-dihydropyrido[2, 3- d ]pyrimidine-4, 7( 3H , 8H )-dione Compounds

Benzylsulfanyl benzo-heterocycle amides and hydrazones as new agents against drug-susceptible and resistant Mycobacterium tuberculosis.

Chemical synthesis and molecular modeling of novel substituted N-1,3-benzoxazol-2yl benzene sulfonamides as inhibitors of inhA enzyme and Mycobacterium tuberculosis growth

Synthesis and Biological Evaluation of 2-(3-fluoro-4-nitro Phenoxy)-N-phenylacetamide Derivatives As Novel Potential Affordable Antitubercular Agents

Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents.

Synthesis, Antitubercular Evaluation of New 2,3-(4-Aminobenzamido)benzoic Acid Derivatives

Synthesis and Evaluation of (S,S)-N,N '-Bis-[3-(2,2 ',6,6 '-Tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) Analogs with Anti-Tuberculosis Activity

Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis

Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase B

Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.

Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles

Synthesis and Structure–activity Relationships Evaluation of Benzothiazinone Derivatives As Potential Anti-Tubercular Agents

Synthesis and Anti-bacterial Activity of New Substituted 2-trifluoromethyl-4-quinolinylhydrazone Analogs against Mycobacterium tuberculosis Strains

QSAR Modeling, Molecular Docking and ADMET Study of Aryl Fluorosulfate Derivatives as Potential Anti-TB Agents

The Optimization and Characterization of Functionalized Sulfonamides Derived from Sulfaphenazole Against Mycobacterium Tuberculosis with Reduced CYP 2C9 Inhibition